1. Everolimus combined with gefitinib in patients with metastatic castration‐resistant prostate cancer: Phase 1/2 results and signaling pathway implications. Issue 21 (15th July 2015) Authors: Rathkopf, Dana E.; Larson, Steven M.; Anand, Aseem; Morris, Michael J.; Slovin, Susan F.; Shaffer, David R.; Heller, Glenn; Carver, Brett; Rosen, Neal; Scher, Howard I. Journal: Cancer Issue: Volume 121:Issue 21(2015) Page Start: 3853 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗